The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary Adenoma

CONTEXT: Growth hormone pituitary adenoma (GHPA), a major subtype of pituitary adenoma (PA), can lead to progressive somatic disfigurement, multiple complications, and even increased mortality. The efficacy of current treatments is limited; thus, a novel pharmacological treatment is urgently needed....

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Chenxing, Xu, Wen, Ding, Hong, Chen, Zhengyuan, Shi, Chengzhang, Han, Jie, Yu, Liang, Qiao, Nidan, Zhang, Yichao, Cao, Xiaoyun, Zhou, Xiang, Cheng, Haixia, Feng, Huijin, Luo, Cheng, Li, Zhiyu, Zhou, Bing, Ye, Zhao, Zhao, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113810/
https://www.ncbi.nlm.nih.gov/pubmed/35247260
http://dx.doi.org/10.1210/clinem/dgac128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113810/
https://www.ncbi.nlm.nih.gov/pubmed/35247260
http://dx.doi.org/10.1210/clinem/dgac128

Ejemplares similares